Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes
European Journal of Pediatrics · 2024
DOI: 10.1007/s00431-024-05772-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Matteo Bramuzzo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Maternal and Child Health (IRCCS) "Burlo Garofolo", Via Dell' Istria 65, 34137, Trieste, Italy. matteo.bramuzzo@burlo.trieste.it. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Hemophagocytic Lymphohistiocytosis (HLH)/Macrophage Activation Syndrome (MAS) in children with inflammatory bowel disease (IBD) has been reported only anecdotally. This study aimed at describing the clinical features and outcomes of children diagnosed with both IBD and HLH/MAS. Data on IBD and HLH/MAS characteristics, biochemical, microbiological and genetic assessments, treatments, and outcomes were collected from the Italian Pediatric IBD Registry and presented using descriptive statistics. Out of 4643 patients with IBD, 18 (0.4%) were diagnosed with HLH/MAS, including 12 with ulcerative colitis and 6 with Crohn disease. Among the 18 patients, 7 (39%) had early-onset IBD, but the median age at HLH/MAS diagnosis was 14.0 years (IQR 11.9-16.0). Half of the patients had active IBD at HLH/MAS diagnosis, 11 (61%) patients were on thiopurines, and 6 (33%) were on anti-TNF biologics. An infectious trigger was identified in 15 (83%) patients. One (5%) patients was diagnosed with XIAP deficiency. All patients discontinued thiopurines and 5 (83.3%) discontinued anti-TNF biologics; 16 (80%) patients received steroids for HLH/MAS. Three (17%) patients had a relapse of HLH/MAS. No patient developed lymphoma or died during a median follow-up of 2.7 years (IQR 0.8-4.4). Conclusions: HLH/MAS mainly affects children with early-onset IBD but primarily develops during adolescence, following an infection while on immunosuppressant treatment. Although the prognosis is generally favorable, it is crucial to investigate an underlying immune deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Maternal and Child Health (IRCCS) "Burlo Garofolo", Via Dell' Istria 65, 34137, Trieste, Italy. matteo.bramuzzo@burlo.trieste.it.
- Unit of Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child With Liver Transplantation, Dpt. of Women's and Children's Health, University Hospital of Padova, Padua, Italy.
- Pediatric Gastroenterology Unit, Maggiore "CA Pizzardi" Hospital, Bologna, Italy.
- Gastroenterology, Digestive Endoscopy and Nutrition Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
- Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
- Pediatric Gastroenterology and Hepatology Unit, Sapienza University of Rome, Umberto I Hospital, Rome, Italy.
Zitieren
APA
Bramuzzo, M., Cananzi, M., Alvisi, P., Cardile, S., Romano, C., Aloi, M., Arrigo, S., Felici, E., Lonoce, L., Pieri, E. S., Scarallo, L., Strisciuglio, C., Di Siena, A., & Lega, S. (2024). Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05772-4
Vancouver
Bramuzzo M, Cananzi M, Alvisi P, Cardile S, Romano C, Aloi M, et al. Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05772-4
BibTeX
@article{Bramuzzo2024,
author = {Bramuzzo, Matteo and Cananzi, Mara and Alvisi, Patrizia and Cardile, Sabrina and Romano, Claudio and Aloi, Marina and Arrigo, Serena and Felici, Enrico and Lonoce, Luisa and Pieri, Elena Sofia and Scarallo, Luca and Strisciuglio, Caterina and Di Siena, Andrea and Lega, Sara},
title = {Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes},
journal = {European Journal of Pediatrics},
year = {2024},
doi = {10.1007/s00431-024-05772-4}
}
EUVIMED